Tscan therapeutics to participate in the td cowen 44th annual health care conference

Waltham, mass., feb. 28, 2024 (globe newswire) -- tscan therapeutics, inc. (nasdaq: tcrx), a clinical-stage biopharmaceutical company focused on the development of t cell receptor (tcr)-engineered t cell therapies (tcr-t) for the treatment of patients with cancer, today announced that the company will participate in the cell therapy corporate panel discussion at the td cowen 44th annual health care conference being held at the marriott copley place in boston on wednesday, march 6, 2024 at 9:10 a.m. eastern time.
TCRX Ratings Summary
TCRX Quant Ranking